Navigation Links
Duska Therapeutics Acquires Technology for ATPotent Sperm Motility Program
Date:10/29/2008

Technology Intended To Reduce Failure Rates Of In Vitro Fertilization and

Intrauterine Insemination Procedures

LA JOLLA, Calif., Oct. 29 /PRNewswire-FirstCall/ -- Duska Therapeutics, Inc. (OTC Bulletin Board: DSKA) announced today that it has entered into a series of agreements to acquire exclusive worldwide rights from several inventors to develop and commercialize technologies relating to the use of adenosine 5'-triphosphate (ATP) to improve motility of human and animal sperm. ATPotent is a novel ATP-based sperm processing medium designed to reduce failure rates of in vitro fertilization (IVF) and intrauterine insemination (IUI) procedures.

Male factor infertility is implicated in about half of the six million infertile couples in the US. Lack of, or low sperm motility or movement, also known as asthenozoospermia, is a common cause of human male infertility. It has been reported in the medical literature that the prevalence of asthenozoospermia in infertile men is approximately 82 percent. Currently, there is no FDA-approved product that enhances sperm motility.

Duska's sponsored studies at the University of Pennsylvania and the University of Padua (Italy) have shown that ATP treatment of poorly motile human sperm in vitro (outside of the human body) resulted in improved motility parameters and increased frequency of hyperactivated sperm. The improved motility parameters were also observed in human sperm derived from males with asthenozoospermia and in thawed cryopreserved human sperm.

Results from these recent studies support earlier observations from a non-Duska sponsored European study in which increased success rate of IVF procedures were observed when ATP-treated sperm derived from infertile males with asthenozoospermia were used.

"Today's announcement underscores Duska's commitment to develop novel targeted therapies utilizing ATP," said Amir Pelleg, PhD, Duska's President and Chief Scientific Offi
'/>"/>

SOURCE Duska Therapeutics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Duska Therapeutics Plans 505(b)(2) NDA Filing Route for ATPace(TM)
2. Duska Therapeutics Sponsored University of Pennsylvania Study Demonstrates ATP Improves Sperm Motility and In Vitro Fertilization in Animals
3. Duska Therapeutics Receives Comments From FDA on Phase 3 ATPace(TM) Protocol Synopsis
4. Prime Therapeutics Receives TIPPS Certification
5. Adams Respiratory Therapeutics to Celebrate 10th Anniversary of its Incorporation on September 12
6. Transition Therapeutics Announces Fiscal 2007 Year End Financial Results
7. Lorus Therapeutics announces election of three new Directors and appoints a new Chairman
8. Deane F. Johnson Center for Neurotherapeutics to Launch First Mobile Medical Unit on October 4th
9. Russell Investment Group Advises Protalix Biotherapeutics of Index Adjustment
10. Adams Respiratory Therapeutics Announces FDA Approval of Grape-Flavored Delsym(R)
11. Prime Therapeutics Announces URAC Accreditation

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/29/2009)...ral Dentistry (AGD) announces that Aria Irvani, DD...ard during the AGD,s commencement celebration that...in dental education.,To accomplish this, Dr. Irva...ntal education in the 16 disciplines of dentistry,...and techniques. , (PRWEB)...
(Date:11/29/2009)...rs-in-training how to do ultrasound-guided procedu...thout compromising patient care and safety, accord...he study shows that this simulation-based training...residents, knowledge, dexterity and confidence for...ded procedures, including breast biopsies, liver b...
(Date:11/29/2009)...form between brain cells almost immediately as ani...hed this week in Nature . Led by researchers at t... involved detailed observations of the rewiring pr...learning. , The researchers studied mice as they...d. They observed rapid growth of structures that f...
(Date:11/29/2009)...swire/ -- Acuo Technologies, developers of high-pe...migration tools and services, today announced a ne...age sharing across the networks of hospitals, clin... is based on the versatile Acuo Technologies DICOM...nables secure access from various PACS to medical ...
(Date:11/29/2009)...eads to more self-defensive finger pointing, study...ws) -- The blame game is a contagious one, a new s..., Researchers found that when people see someone ...unfair accusation, they,re much more likely to eng...ers protecting their egos, we become defensive, to...
Breaking Medicine News(10 mins):Health News:Orange County Dentist Honored by The Academy of General Dentistry 2Health News:Simulated training for ultrasound-guided procedures improves safety without risk to patients 2Health News:Study shows new brain connections form rapidly during motor learning 2Health News:Study shows new brain connections form rapidly during motor learning 3Health News:Acuo Technologies Announces a New Offering That Enables Sharing of Imaging Studies Securely and Affordably 2Health News:When Accusations Start to Fly, They Multiply 2
...rican Physical Therapy Association (APTA) is urgin...reatment by a physical therapist, in light of a ne...of American adults and nearly 12 percent of childr...e released Dec. 11 by the National Institutes of H...
...of Denver (DU) Associate Professor Rene Botta sugg...raduate students to wash their hands more frequent... 2007, researchers posted messages in the bathroom...ined vivid graphics and photos. The messages resul...
...DS joins PEPFAR, Nike Foundation, Coca-Cola Africa...ree Generation , , NAIROBI, Kenya, Dec. 15 A...d at disadvantaged young people in Nairobi will re... Those efforts, in turn, are intended to help you...
... Food,and Drug Administration (FDA) approved Abbot... capsules for use along with diet to help lower tr...cholesterol in patients with lipid,problems. TRIL...nation of a fibrate with a statin to further impro...
...paign for Tobacco-Free Kids , , WASHINGTON, D... major victory for consumers and public health by ...ion laws to sue Philip Morris and other tobacco co...n important step toward holding cigarette manufact...
...to Controlling Costs, Improving Quality as Health ...ice , , WASHINGTON, Dec. 15 House Ways and M... , D-Calif., and Liz Fowler , senior counsel to S...on a conference call with reporters on Wednesday t...
Other Medicine News:Health News:Physical therapy offers evidence-based solution to musculoskeletal pain 2Health News:University of Denver uses 'gross' messaging to increases handwashing, fight Norovirus 2Health News:Rotary Action Group Helps Launch Major Public-Private HIV Prevention Initiative in Kenya 2Health News:Rotary Action Group Helps Launch Major Public-Private HIV Prevention Initiative in Kenya 3Health News:Abbott Receives FDA Approval for TRILIPIX(TM) (fenofibric acid), First and Only Fibrate Indicated for Use in Combination With a Statin for Cholesterol Management 2Health News:Abbott Receives FDA Approval for TRILIPIX(TM) (fenofibric acid), First and Only Fibrate Indicated for Use in Combination With a Statin for Cholesterol Management 3Health News:Abbott Receives FDA Approval for TRILIPIX(TM) (fenofibric acid), First and Only Fibrate Indicated for Use in Combination With a Statin for Cholesterol Management 4Health News:U.S. Supreme Court Ruling Allowing Light Cigarette Lawsuits Is Victory for Consumers and Health 2Health News:U.S. Supreme Court Ruling Allowing Light Cigarette Lawsuits Is Victory for Consumers and Health 3
(Date:11/29/2009)... CHICAGO, Nov. 29 At the 95th...iological Society of North America (RSNA) from Nov...go , Siemens Healthcare will introduce its compre...cology at booth #825, East Building/Lakeside Cen...procedures for cancer therapy, the interventio...
(Date:11/29/2009)...CHICAGO, Nov. 29 At the 95th Scie...ical Society of North America (RSNA), "Images, my ...re booth (#825) from November 29 to December 3 at ...e Center, Hall D) in Chicago. This year,s booth di...iemens support for its customers to generate, proc...
(Date:11/29/2009)..., CHICAGO, Nov. 29 Royal Philips E...sponse to an industry need by showing its portfoli... this year,s 95th annual meeting of the Radiologic...w this year from Philips are several advancements ...ng dose radiation and streamlining workflow to exp...
Breaking Medicine Technology:Minimally Invasive Procedure for Oncology 2Minimally Invasive Procedure for Oncology 3Minimally Invasive Procedure for Oncology 4Minimally Invasive Procedure for Oncology 5Siemens Delivers Images per the Customer's Request - 'Images My Way' 2Siemens Delivers Images per the Customer's Request - 'Images My Way' 3Siemens Delivers Images per the Customer's Request - 'Images My Way' 4Siemens Delivers Images per the Customer's Request - 'Images My Way' 5Siemens Delivers Images per the Customer's Request - 'Images My Way' 6Siemens Delivers Images per the Customer's Request - 'Images My Way' 7Siemens Delivers Images per the Customer's Request - 'Images My Way' 8Siemens Delivers Images per the Customer's Request - 'Images My Way' 9Philips Responds to Industry Concerns With Focus on Radiation Dose Management Products Designed for Clinicians and Patients 2Philips Responds to Industry Concerns With Focus on Radiation Dose Management Products Designed for Clinicians and Patients 3Philips Responds to Industry Concerns With Focus on Radiation Dose Management Products Designed for Clinicians and Patients 4Philips Responds to Industry Concerns With Focus on Radiation Dose Management Products Designed for Clinicians and Patients 5GettingHired Announces Additional Funding for Continued Growth as Well as R 26amp 3BD of New Product for Long Term Disability and Workers Comp 61669 1GettingHired Announces Additional Funding for Continued Growth as Well as R 26amp 3BD of New Product for Long Term Disability and Workers Comp 61669 2GettingHired Announces Additional Funding for Continued Growth as Well as R 26amp 3BD of New Product for Long Term Disability and Workers Comp 61669 3Acclaimed American Journalist Awarded Excellence In Journalism by American Society of Tropical Medicine and Hygiene 61666 1Acclaimed American Journalist Awarded Excellence In Journalism by American Society of Tropical Medicine and Hygiene 61666 2Sangamo BioSciences Provides Update on Phase 1 Safety Trial of SB 728 T for HIV AIDS 14909 1Sangamo BioSciences Provides Update on Phase 1 Safety Trial of SB 728 T for HIV AIDS 14909 2
...RE)--Jun 6, 2007 - Gilead,Sciences, Inc. (Nasdaq:G...linical trial evaluating the company,s once-daily,...e or tenofovir,DF) 300 mg as a potential treatment...t its primary efficacy endpoint. The study shows,t...aily antiviral,drug Hepsera(R) (adefovir dipivoxil...
...ux - , Waltham, Mass., June 7, 2007 – Dynoge...of its randomized, double-blind,placebo-controlle...flux disease (GERD). The study was designed to de...nt for nocturnal GERD,(NGERD). The 0.5 mg dose o...acebo on the primary endpoint of reduction in,the ...
Other Medicine Technology:Phase III Study Evaluating Gilead's Viread for the Treatment of,Chronic Hepatitis B Virus Meets Primary Endpoint 2Phase III Study Evaluating Gilead's Viread for the Treatment of,Chronic Hepatitis B Virus Meets Primary Endpoint 3Phase III Study Evaluating Gilead's Viread for the Treatment of,Chronic Hepatitis B Virus Meets Primary Endpoint 4Phase III Study Evaluating Gilead's Viread for the Treatment of,Chronic Hepatitis B Virus Meets Primary Endpoint 5Phase III Study Evaluating Gilead's Viread for the Treatment of,Chronic Hepatitis B Virus Meets Primary Endpoint 6Phase III Study Evaluating Gilead's Viread for the Treatment of,Chronic Hepatitis B Virus Meets Primary Endpoint 7Dynogen's DDP733 Reduces Reflux in Phase 1b GERD Study 2Dynogen's DDP733 Reduces Reflux in Phase 1b GERD Study 3
...vel of engineering and innovative design, the Burt...n, unparalleled quality and masterful workmanship....almic industry a truly innovative concept, but to ...quality construction and stringent testing, we dev...
...mporary Soft Touch control panel with 3 charging w...k, Colonial Blue and Cinnamon. Spring balanced ref...teel construction for lifelong quality. Sealed hyd...wn chair movement. Chair back reclines manually to...
...ar warranty Set one of two memory positions to aut...e touch auto return button, Durable upholstery,...id-State push button control panel with three rech...lectro-Magnetic counter-balanced slit lamp arm for...
...ol Ophthalmics™ Balanced Salt Solution (Ster...late, physiologic solution which is isotonic to oc... normal cellular metabolic functions. Each 1.0 mL ...SP .48 mg, Magnesium Chloride Hexahydrate (MgCl2 ...
Medicine Products: